Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO) specialising in the development and manufacture of innovative drug formulations, has been announced as a winner of the King’s Award for Enterprise, International Trade.
The King’s Award for Enterprise is a highly prestigious award for UK businesses who have demonstrated outstanding innovation in their industry.
The award represents a key milestone for Upperton and a significant achievement following high growth since 2020, acknowledging Upperton’s outstanding contributions to international trade and its commitment to fostering global partnerships within the pharmaceutical industry.
We are honoured to receive the King's Award for International Trade, recognising our efforts in advancing pharmaceutical innovation on a global scale.
Upperton secured the award as a result of its market-leading work in the development of liquid and dry powder pharmaceutical dosage forms used in clinical trials across the world including Taiwan, Sweden, USA, Italy, Switzerland, Ireland, Israel, Australia, France, Norway, Belgium, Germany, and Spain. Upperton has achieved significant overseas sales growth year on year through technical expertise and MHRA licenced facilities.
“We are honoured to receive the King’s Award for International Trade, recognising our efforts in advancing pharmaceutical innovation on a global scale,” said Nikki Whitfield, CEO of Upperton Pharma Solutions. “This prestigious award underscores our team’s dedication to our vision and values, providing superior services to our clients worldwide, as well as our commitment to innovative drug development.”
Commitment to pharmaceutical development
With a dedication to excellence, Upperton Pharma Solutions has demonstrated exceptional prowess in expanding its footprint across international markets. The King’s Award for International Trade stands as a testament to the company’s unwavering commitment to delivering high-quality pharmaceutical development and manufacturing services on a global scale.
To acknowledge the achievement and receive the award, Upperton welcomed the esteemed Sir John Peace, Lord- Lieutenant, Mark Goldby DL, Deputy Lieutenant, Darren Henry, Member of Parliament for Broxtowe, and Inflexion investment directors to the new £15m, 50,000 sq. ft. facility, Trent Gateway.
“We were thrilled to find out that we had won The King’s Awards for Enterprise and International Trade and had the pleasure of welcoming a few special guests to our facility to receive the award and share the achievement with our dedicated colleagues” said Dr Richard Johnson, Founder and CSO of Upperton Pharma Solutions.
